Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Group rumination-focused cognitive-behavioural therapy (CBT) v. group CBT for depression: phase II trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Assessing risk of neurodevelopmental disorders after birth with oxytocin: a systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Rumination-focused cognitive behaviour therapy for non-responsive chronic depression: an uncontrolled group study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Promoting well-being in psychosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Although cognitive-behavioural therapy (CBT) is an effective treatment for depression, less than half of patients achieve satisfactory symptom reduction during treatment. Targeting known psychopathological processes such as rumination may increase treatment efficacy. The aim of this study was to test whether adding group rumination-focused CBT (RFCBT) that explicitly targets rumination to routine medical management is superior to adding group CBT to routine medical management in treating major depression.

METHODS: A total of 131 outpatients with major depression were randomly allocated to 12 sessions group RFCBT v. group CBT, each in addition to routine medical management. The primary outcome was observer-rated symptoms of depression at the end of treatment measured on the Hamilton Rating Scale for Depression. Secondary outcomes were rumination at post-treatment and depressive symptoms at 6 months follow-up (Trial registered: NCT02278224).

RESULTS: RFCBT significantly improved observer-rated depressive symptoms (Cohen's d 0.38; 95% CI 0.03-0.73) relative to group CBT at post-treatment on the primary outcome. No post-treatment differences were found in rumination or in depressive symptoms at 6 months follow-up, although these secondary analyses may have been underpowered.

CONCLUSIONS: This is the first randomized controlled trial providing evidence of benefits of RFCBT in major depression compared with CBT. Group RFCBT may be a beneficial alternative to group CBT for major depression.

OriginalsprogEngelsk
TidsskriftPsychological Medicine
Sider (fra-til)1-9
Antal sider9
ISSN0033-2917
DOI
StatusUdgivet - 11 jan. 2019

ID: 57568252